Login / Signup

Mortality Prediction of the CHA2DS2-VASc Score, the HAS-BLED Score, and Their Combination in Anticoagulated Patients with Atrial Fibrillation.

Doralisa MorroneSonja KroepFabrizio RicciGiulia RendaGiuseppe PattiPaulus F KirchhofLing-Hsiang ChuangBen van HoutRaffaele De Caterina
Published in: Journal of clinical medicine (2020)
Both the CHA2DS2-VASc and the HAS-BLED scores predict mortality similarly in patients with AF, and a combination of their components increases prediction significantly. Such combination may be useful for investigational and-possibly-also clinical purposes.
Keyphrases
  • atrial fibrillation
  • cardiovascular events
  • risk factors
  • clinical trial
  • type diabetes
  • coronary artery disease
  • phase ii